|
儿童感染后闭塞性细支气管炎治疗进展
|
Abstract:
闭塞性细支气管炎(Bronchiolitis Obliterans, BO)是一组以反复或持续性呼吸困难及气流受阻为主要特点的慢性气流阻塞综合征。感染是儿童BO的最主要病因,又称为感染后闭塞性细支气管炎(Post-infection Bronchiolitis Obliterans, PIBO)。PIBO目前尚无特效治疗,主要药物治疗包括糖皮质激素、阿奇霉素、白三烯受体拮抗剂、支气管扩张剂,非药物治疗包括肺康复训练、营养支持。间充质干细胞、靶向药物治疗可作为未来PIBO治疗的新方向。PIBO早期干预有助于改善患儿预后,现主要就PIBO的治疗进展作一综述。
Bronchiolitis Obliterans (BO) is a chronic airflow obstruction syndrome characterized by recurrent or persistent dyspnea and airflow obstruction. Infection is the primary cause of BO in children, also known as post-infection bronchiolitis obliterans (PIBO). Nowadays, there is no specific treatment, glucocorticoid, azithromycin, leukotriene receptor antagonist and bronchodilator are mainly used in drug therapy. The main non-drug therapy is pulmonary rehabilitation training and nutritional support. Early intervention can improve the prognosis, in this article, the treatment of PIBO is introduced mainly.
[1] | 严永东, 戴鸽. 儿童腺病毒肺炎并闭塞性细支气管炎的诊治进展[J]. 中华实用儿科临床杂志, 2020, 35(22): 1685-1689. |
[2] | 李丹, 张玉玲. 儿童闭塞性细支气管炎的诊疗进展[J]. 医学综述, 2020, 26(19): 3870-3876. |
[3] | 戴鸽, 王婷, 蒋吴君, 等. 腺病毒肺炎后闭塞性细支气管炎37例临床分析[J]. 中华实用儿科临床杂志, 2020, 35(16): 1235-1238. |
[4] | Lee, E. and Young Lee, Y. (2020) Risk Factors for the Development of Post-Infectious Bronchiolitis Obliterans after Mycoplasma pneumoniae Pneumonia in the Era of Increasing Macrolide Resistance. Respiratory Medicine, 175, Article ID: 106209. https://doi.org/10.1016/j.rmed.2020.106209 |
[5] | Zheng, H.Q., Ma, Y.C., Chen, Y.Q., et al. (2022) Clinical Analysis and Risk Factors of Bronchiolitis Obliterans after Mycoplasma pneumoniae Pneumonia. Infection and Drug Resistance, 15, 4101-4108.
https://doi.org/10.2147/IDR.S372940 |
[6] | Jung, J.H., Kim, G.E., Min, I.K., et al. (2021) Prediction of Postinfectious Bronchiolitis Obliterans Prognosis in Children. Pediatric Pulmonology, 56, 1069-1076. https://doi.org/10.1002/ppul.25220 |
[7] | Chan, K.C., Yu, M.W., Cheung, T.W.Y., et al. (2021) Childhood Bron-chiolitis Obliterans in Hong Kong—Case Series over a 20-Year Period. Pediatric Pulmonology, 56, 153-161. https://doi.org/10.1002/ppul.25166 |
[8] | Wang, X., Tan, X. and Li, Q. (2022) The Difference in Clinical Features and Prognosis of Severe Adenoviral Pneumonia in Children of Different Ages. Journal of Medical Virology, 94, 3303-3311. https://doi.org/10.1002/jmv.27680 |
[9] | 伊丽丽. 儿童感染后闭塞性细支气管炎研究进展[J]. 国际儿科学杂志, 2021, 48(4): 271-275. |
[10] | Duecker, R.P., De Mir Messa, I., Jerkic, S.P., et al. (2022) Epigenetic Regu-lation of Inflammation by microRNAs in Post-Infectious Bronchiolitis Obliterans. Clinical & Translational Immunology, 11, e1376.
https://doi.org/10.1002/cti2.1376 |
[11] | ?i?manlar Eyübo?lu, T., Aslan, A.T., Ramasl? Gürsoy, T., et al. (2022) Caspase-1 and Interleukin-18 in Children with Post Infectious Bronchiolitis Obliterans: A Case-Control Study. European Journal of Pediatrics, 181, 3093-3101.
https://doi.org/10.1007/s00431-022-04528-2 |
[12] | Gulla, K.M., Jat, K.R., Lodha, R., et al. (2020) Clinical Profile and Course of Children with Postinfectious Bronchiolitis Obliterans from a Tertiary Care Hospital. Lung India, 37, 8-12. https://doi.org/10.4103/lungindia.lungindia_145_19 |
[13] | Yazan, H., Khalif, F., Shadfaan, L.A., et al. (2021) Post-Infectious Bronchiolitis Obliterans in Children: Clinical and Radiological Evaluation and Long-Term Results. Heart & Lung, 50, 660-666.
https://doi.org/10.1016/j.hrtlng.2021.05.001 |
[14] | Jerkic, S.P., Brinkmann, F., Calder, A., et al. (2020) Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report. Canadian Respiratory Journal, 2020, Article ID: 5852827.
https://doi.org/10.1155/2020/5852827 |
[15] | Kang, M.J., Ahn, H.S., Lee, S.Y., et al. (2022) TGFβ1 and POSTN as Biomarkers of Postinfectious Bronchiolitis Obliterans and Asthma in Children. Pediatric Pulmonology, 57, 3161-3164. https://doi.org/10.1002/ppul.26139 |
[16] | Zheng, H., Yu, X., Chen, Y., et al. (2022) Effects of Inhaled Corticoster-oids on Lung Function in Children with Post-Infectious Bronchiolitis Obliterans in Remission. Frontiers in Pediatrics, 10, Article ID: 827508.
https://doi.org/10.3389/fped.2022.827508 |
[17] | 谢诚, 刘燕茹, 艾涛, 等. 雾化吸入布地奈德溶液治疗儿童闭塞性细支气管炎疗效观察[J]. 儿科药学杂志, 2021, 27(5): 12-15. |
[18] | Kim, K.H., Lee, J., Kim, H.J., et al. (2020) Efficacy and Safety of High-Dose Budesonide/Formoterol in Patients with Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplant. Journal of Thoracic Disease, 12, 4183-4195. https://doi.org/10.21037/jtd-19-3475 |
[19] | Kavaliunaite, E. and Aurora, P. (2019) Diagnosing and Managing Bronchiolitis Obliterans in Children. Expert Review of Respiratory Medicine, 13, 481-488. https://doi.org/10.1080/17476348.2019.1586537 |
[20] | 林继雷, 郑雪香, 钟林平, 等. 小剂量阿奇霉素辅助治疗儿童闭塞性细支气管炎临床疗效分析[J]. 儿科药学杂志, 2019, 25(1): 18-20. |
[21] | Arjuna, A., Olson, M.T., Walia, R., et al. (2021) An Update on Current Treatment Strategies for Managing Bronchiolitis Obliterans Syndrome after Lung Transplantation. Expert Review of Respiratory Medicine, 15, 339-350.
https://doi.org/10.1080/17476348.2021.1835475 |
[22] | Gan, C.T., Ward, C., Meachery, G., et al. (2019) Long-Term Effect of Azithromycin in Bronchiolitis Obliterans Syndrome. BMJ Open Respiratory Research, 6, e000465. https://doi.org/10.1136/bmjresp-2019-000465 |
[23] | Li, D., Duan, Q., Weinkauf, J., et al. (2020) Azithromycin Prophylaxis after Lung Transplantation Is Associated with Improved Overall Survival. The Journal of Heart and Lung Transplantation, 39, 1426-1434.
https://doi.org/10.1016/j.healun.2020.09.006 |
[24] | Hao, X., Peng, C., Lian, W., et al. (2022) Effect of Azithromycin on Bronchiolitis Obliterans Syndrome in Posttransplant Recipients: A Systematic Review and Meta-Analysis. Medicine (Baltimore), 101, e29160.
https://doi.org/10.1097/MD.0000000000029160 |
[25] | Weng, T., Lin, X., Wang, L., et al. (2021) Follow-Up on the Therapeutic Effects of a Budesonide, Azithromycin, Montelukast, and Acetylcysteine (BAMA) Regimen in Children with Post-Infectious Bronchiolitis Obliterans. Journal of Thoracic Disease, 13, 4775-4784. https://doi.org/10.21037/jtd-20-3195 |
[26] | Chen, X., Shu, J.H., Huang, Y., et al. (2020) Therapeutic Effect of Budesonide, Montelukast and Azithromycin on Post-Infectious Bronchiolitis Obliterans in Children. Experimental and Therapeutic Medicine, 20, 2649-2656.
https://doi.org/10.3892/etm.2020.8983 |
[27] | 游红亮, 丁艳杰, 陈娇, 等. 儿童造血干细胞移植后闭塞性细支气管炎综合征7例临床分析[J]. 中华实用儿科临床杂志, 2022, 37(10): 774-777. |
[28] | 赵玮, 石玉铸, 赵艳丽, 等. 儿童异基因造血干细胞移植后非感染性肺部并发症及相关气漏综合征临床分析[J]. 中国小儿血液与肿瘤杂志, 2022, 27(4): 226-231. |
[29] | Yu, X., Wei, J., Li, Y., et al. (2021) Longitudinal Assessment of Pulmonary Function and Bronchodilator Response in Pediatric Patients with Post-infectious Bronchiolitis Obliterans. Frontiers in Pediatrics, 9, Article ID: 674310.
https://doi.org/10.3389/fped.2021.674310 |
[30] | Zhang, X.M., Lu, A.Z., Yang, H.W., et al. (2018) Clinical Features of Postinfectious Bronchiolitis Obliterans in Children Undergoing Long-Term Nebulization Treatment. World Journal of Pediatrics, 14, 498-503.
https://doi.org/10.1007/s12519-018-0193-z |
[31] | 赖世维, 黄烈平, 顾海红, 等. 特布他林联合布地奈德雾化吸入治疗小儿闭塞性细支气管炎的疗效及安全性探讨[J]. 中国基层医药, 2018, 25(12): 1525-1528. |
[32] | Matthay, M.A., Calfee, C.S., Zhuo, H., et al. (2019) Treatment with Allogeneic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome (START Study): A Randomised Phase 2A Safety Trial. The Lancet Res-piratory Medicine, 7, 154-162. https://doi.org/10.1016/S2213-2600(18)30418-1 |
[33] | Chen, S., Zhao, K., Lin, R., et al. (2019) The Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study. EBioMedicine, 49, 213-222.
https://doi.org/10.1016/j.ebiom.2019.09.039 |
[34] | Lin, J., Deng, H., Zhang, Y., et al. (2021) Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells on Murine Model of Bronchiolitis Obliterans like Injury. Pediatric Pulmonology, 56, 129-137.
https://doi.org/10.1002/ppul.25128 |
[35] | Hodge, G., Hodge, S., Liu, H., et al. (2021) Bronchiolitis Obliterans Syndrome Is Associated with Increased Senescent Lymphocytes in the Small Airways. The Journal of Heart and Lung Transplantation, 40, 108-119.
https://doi.org/10.1016/j.healun.2019.12.005 |
[36] | Chakraborty, D., Shepherd, J., Gregor, J., et al. (2021) The Tricky Trachea: Tracheitis and Mediastinitis Treated with Infliximab and Steroids in a Patient with Ulcerative Colitis. Chest, 160, e255-e258.
https://doi.org/10.1016/j.chest.2021.03.060 |
[37] | Streiler, C., Shaikh, F., Davis, C., et al. (2020) Ruxolitinib Is an Effective Steroid Sparing Agent in Bronchiolitis Obliterans Due to Chronic Graft-versus-Host-Disease. Bone Marrow Transplantation, 55, 1194-1196.
https://doi.org/10.1038/s41409-019-0662-6 |
[38] | Schoettler, M., Duncan, C., Lehmann, L., et al. (2019) Ruxolitinib Is an Effective Steroid Sparing Agent in Children with Steroid Refractory/Dependent Bronchiolitis Obliterans Syndrome after Allogenic Hematopoietic Cell Transplantation. Bone Marrow Transplantation, 54, 1158-1160. https://doi.org/10.1038/s41409-019-0450-3 |
[39] | Tang, W., Yu, T., Dong, T., et al. (2020) Nintedanib in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation. Chest, 158, e89-e91. https://doi.org/10.1016/j.chest.2020.05.557 |
[40] | 姜源, 徐红贞, 陈志敏. 儿童肺康复应用进展[J]. 中华实用儿科临床杂志, 2022, 37(18): 1434-1437. |
[41] | Choi, H.E., Lim, S.N., Lee, J.H., et al. (2020) Comprehensive Pulmonary Rehabilitation in Patients with Bronchiolitis Obliterans Syndrome: A Case Series. Respiratory Medicine Case Reports, 31, Article ID: 101161.
https://doi.org/10.1016/j.rmcr.2020.101161 |
[42] | Choi, E.J., Kim, W., Jeon, J.Y., et al. (2021) Intensive Pulmonary Rehabilitation in a Pediatric Lung Transplantation Patient: A Case Report. Medicine (Baltimore), 100, e25523. https://doi.org/10.1097/MD.0000000000025523 |
[43] | Bosa, V.L., Mello, E.D., Mocelin, H.T., et al. (2008) As-sessment of Nutritional Status in Children and Adolescents with Post-Infectious Bronchiolitis Obliterans. The Journal of Pediatrics (Rio J), 84, 323-330.
https://doi.org/10.2223/JPED.1812 |
[44] | 党媛媛, 韩聪莉, 严华, 等. 反复呼吸道感染患儿免疫功能及两种维生素的变化[J]. 国际检验医学杂志, 2019, 40(9): 1124-1127. |
[45] | 彭贻界, 李正涛, 邓宏艳. 维生素A对闭塞性细支气管炎患儿疗效的影响[J]. 中南医学科学杂志, 2020, 48(4): 425-427. |
[46] | Chen, W., Zhao, L., Guo, L., et al. (2022) Clinical and Pathological Features of Bronchiolitis Obliterans Requiring Lung Transplantation in Paraneoplastic Pemphigus Associated with Castleman Disease. The Clinical Respiratory Journal, 16, 173-181. https://doi.org/10.1111/crj.13465 |
[47] | Yue, B., Huang, J., Jing, L., et al. (2022) Bilateral Lung Transplantation for Castleman Disease with End-Stage Bronchiolitis Obliterans. Clinical Transplantation, 36, e14496. https://doi.org/10.1111/ctr.14496 |